Literature DB >> 12749748

Medical management of nocturnal symptoms of gastro-oesophageal reflux disease in the elderly.

Samer Gawrieh1, Reza Shaker.   

Abstract

Elderly patients with nocturnal symptoms of gastro-oesophageal reflux disease (GORD) usually experience a more aggressive and complicated disease course compared with younger patients, resulting in impaired quality of life. The severity of disease and possible complications should be evaluated with upper endoscopy once the diagnosis is suspected. Elderly patients with nocturnal symptoms of GORD and evidence of endoscopic complications (oesophagitis, Barrett's oesophagus, etc.) and those with severe endoscopically negative reflux disease (ENRD) should be treated with proton pump inhibitors. Histamine H(2) receptor antagonists are suitable for mild-to-moderate ENRD. Antacids and lifestyle modifications may be incorporated into the management as adjuncts to more potent and durable therapeutic agents. Effective treatment of nocturnal GORD symptoms in the elderly will result in relief of symptoms, healing of oesophagitis and improved quality of life, and should be maintained indefinitely to prevent relapses of the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12749748     DOI: 10.2165/00002512-200320070-00003

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  64 in total

Review 1.  Medical therapy for gastroesophageal reflux disease.

Authors:  A S Arora; D O Castell
Journal:  Mayo Clin Proc       Date:  2001-01       Impact factor: 7.616

2.  Cisapride and metoclopramide in the treatment of gastroesophageal reflux disease.

Authors:  J T Arabehety; O R Leitão; S Fassler; M Olarte; C Serrano
Journal:  Clin Ther       Date:  1988       Impact factor: 3.393

3.  Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux.

Authors:  L B Gerson; R Edson; P W Lavori; G Triadafilopoulos
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

4.  Survey of primary care physicians' approach to gastroesophageal reflux disease in elderly patients.

Authors:  C M Wilcox; G Heudebert; J Klapow; R Shewchuk; L Casebeer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-08       Impact factor: 6.053

5.  Associations between different forms of gastro-oesophageal reflux disease.

Authors:  H B el-Serag; A Sonnenberg
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

Review 6.  Selection of drugs to treat gastro-oesophageal reflux disease: the role of drug interactions.

Authors:  D A Flockhart; Z Desta; S K Mahal
Journal:  Clin Pharmacokinet       Date:  2000-10       Impact factor: 6.447

7.  Methodological aspects of evaluation of Quality of Life in upper gastrointestinal diseases.

Authors:  E Dimenäs
Journal:  Scand J Gastroenterol Suppl       Date:  1993

8.  Effects of sleeping with the bed-head raised and of ranitidine in patients with severe peptic oesophagitis.

Authors:  R F Harvey; P C Gordon; N Hadley; D E Long; T R Gill; R I Macpherson; B C Beats; A J Tottle
Journal:  Lancet       Date:  1987-11-21       Impact factor: 79.321

Review 9.  Metoclopramide-induced movement disorders. Clinical findings with a review of the literature.

Authors:  L G Miller; J Jankovic
Journal:  Arch Intern Med       Date:  1989-11

10.  A comparison of five maintenance therapies for reflux esophagitis.

Authors:  S Vigneri; R Termini; G Leandro; S Badalamenti; M Pantalena; V Savarino; F Di Mario; G Battaglia; G S Mela; A Pilotto
Journal:  N Engl J Med       Date:  1995-10-26       Impact factor: 91.245

View more
  1 in total

1.  Influence of age on outcome of total laparoscopic fundoplication for gastroesophageal reflux disease.

Authors:  F Pizza; G Rossetti; P Limongelli; G Del Genio; V Maffettone; V Napolitano; L Brusciano; G Russo; S Tolone; M Di Martino; A Del Genio
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.